Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1230 to 1279 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein hox-b9 (hox-2e) (hox-2.5). [source:swissprot;acc:p17482]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.257\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 202.132\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05999\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 616\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein hox-a9 (hox-1g). [source:swissprot;acc:p31269]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 177.698\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 190.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.542\vspace{3pt}}\\\cline{1-2}\cline{5-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 617\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent 190.239\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.541\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein hox-c9 (hox-3b). [source:swissprot;acc:p31274]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.257\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.135\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05997\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 618\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 177.699\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 190.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.541\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 619\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vam6/vps39-like protein (hvam6p). [source:swissprot;acc:q96jc1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.274\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.792\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.518\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 620\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent microtubule-associated protein 4 (map 4). [source:swissprot;acc:p27816]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.274\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.792\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.518\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 621\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s acidic ribosomal protein p2. [source:swissprot;acc:p05387]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 231.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 244.435\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.515\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 202.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 622\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 623\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 624\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent interleukin-1 receptor-associated kinase 4; interleukin-1 receptor associated kinase 4. [source:refseq;acc:nm\_016123]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 625\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 202.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 626\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 627\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 628\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 629\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05994\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal targeting signal 1 receptor (peroxismore receptor 1) (peroxisomal c-terminal targeting signal import receptor) (pts1-bp) (peroxin-5) (pts1 receptor). [source:swissprot;acc:p50542]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 630\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent hairy/enhancer-of-split related with yrpw motif 2; gridlock; hes-related repressor protein 1. [source:refseq;acc:nm\_012259]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase b14 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b14) (ci-b14). [source:swissprot;acc:p56556]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 202.141\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05993\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 631\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent similar to expressed sequence aa415817. [source:sptrembl;acc:q8n4q9]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transcription factor hes-1 (hairy and enhancer of split 1) (hairy- like) (hhl) (hairy homolog). [source:swissprot;acc:q14469]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 632\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein hox-d9 (hox-4c) (hox-5.2). [source:swissprot;acc:p28356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.166\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05979\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 633\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent alanyl-trna synthetase (ec 6.1.1.7) (alanine--trna ligase) (alars). [source:swissprot;acc:p49588]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.106\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 248.104\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05979\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 634\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dead-box protein abstrakt homolog. [source:swissprot;acc:q9ujv9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 226.523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.786\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05958\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.496\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 635\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l37 (g1.16). [source:swissprot;acc:p02403]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 242.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05957\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mevalonate kinase (ec 2.7.1.36) (mk). [source:swissprot;acc:q03426]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.296\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 247.673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.377\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 636\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 1 (pre-mrna splicing factor sf2, p33 subunit) (alternative splicing factor asf-1). [source:swissprot;acc:q07955]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 242.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05957\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 199.849\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.351\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 637\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent amidophosphoribosyltransferase precursor (ec 2.4.2.14) (glutamine phosphoribosylpyrophosphate amidotransferase) (atase) (gpat). [source:swissprot;acc:q06203]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 242.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05957\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vav-3 protein. [source:swissprot;acc:q9ukw4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 199.908\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.345\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 638\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent sorting nexin 17. [source:swissprot;acc:q15036]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 242.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05957\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vav-2 protein. [source:swissprot;acc:p52735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.526\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.314\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 639\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleoporin-like protein rip (hiv-1 rev-binding protein) (rev interacting protein) (rev/rex activation domain-binding protein). [source:swissprot;acc:p52594]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 230.596\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05938\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rna-binding protein nova-1 (neuro-oncological ventral antigen 1) (onconeural ventral antigen-1) (paraneoplastic ri antigen) (ventral neuron-specific protein 1). [source:swissprot;acc:p51513]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.847\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.293\vspace{3pt}}\\\cline{1-2}\cline{4-6} \parbox{\wcA}{\vspace{3pt}\noindent 640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h3.3 (h3.a) (h3.b) (h3.3q). [source:swissprot;acc:p06351]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 244.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.577\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 12.265\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/